GSE123619
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq]
Expression profiles of 22RV1 prostate cancer cells following FOXA1 genetic engineering and or TLE3 knock-down Overall design: treatment control design with biological replicates (n=2)